The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Article Details

Citation

Tsujino S, Shanske S, Sakoda S, Fenichel G, DiMauro S

The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Am J Hum Genet. 1993 Mar;52(3):472-7.

PubMed ID
8447317 [ View in PubMed
]
Abstract

The glycolytic enzyme phosphoglycerate mutase (PGAM) is a dimer, and mature human skeletal muscle contains almost exclusively the MM form of the enzyme, PGAM-M. In 1981, we identified a patient with PGAM-M deficiency, and three additional patients have since been described. All presented with exercise intolerance, cramps, and myoglobinuria. We report two new patients with PGAM-M deficiency and describe the molecular lesions in five patients--four African-Americans and one Caucasian. Three patients were homozygous for an identical G-to-A transition converting an encoded Trp to an in-frame stop codon (codon 78). A fourth patient was heterozygous for this mutation and also carried an A-to-C mutation converting Glu to Ala (codon 89). The fifth patient, the only Caucasian, was homozygous for a different point mutation, a C-to-T mutation, converting Arg to Trp (codon 90).

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Phosphoglycerate mutase 2P15259Details